Recommendations of the Spanish Society of Neonatology for the prevention of severe respiratory syncytial virus infections with nirsevimab, for the 2024-2025 season
Saved in:
Main Authors: | Manuel Sánchez Luna (Author), M. Luz Couce Pico (Author), Belén Fernández Colomer (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recommendations of the Spanish Society of Pediatric Cardiology and Congenital Heart Diseases for the prevention of respiratory syncytial virus infections with nirsevimab in pediatric cardiology
by: Constancio Medrano López, et al.
Published: (2024) -
An update of the recommendations of the spanish neonatology society for the use of paivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants
by: Manuel Sánchez Luna, et al.
Published: (2019) -
Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants - Importance of design
by: Getu Zhaori
Published: (2023) -
Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain
by: Jaime Jesús Pérez Martín, et al.
Published: (2024) -
Health care-associated infections in neonatology
by: María Cernada, et al.
Published: (2024)